Therapeutic Asset Ratings

91,565 assets7,904 sponsors3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Fludarabine Lymphoblastic Lymphoma	Ohio State University Comprehensive Cancer Center	P3	BB (66)
Fludarabine Disease Related To Transplantation	M.D. Anderson Cancer Center	P3	BB (66)
Fludeoxyglucose Non-Small Cell Lung Carcinoma	Alliance for Clinical Trials in Oncology	P3	BB (66)
Fludrocortisone Congenital Adrenal Hyperplasia	University of Texas Southwestern Medical Center	P3	BB (66)
Fluorine (18F) Psma 1007 Prostate Cancer	Novartis Pharmaceuticals	P3	BB (66)
Fluorouracilum Cancer	Sixth Affiliated Hospital, Sun Yat-sen University	P3	BB (66)
Fluorouracilum Peritoneum Cancer	City of Hope Medical Center	P3	BB (66)
Frsw117 Severe Hemophilia A	Hangzhou Gensciences Biopharmaceutical Co., Ltd.	P3	BB (66)
Fruquintinib Non-Small Cell Lung Carcinoma	Immunitas Therapeutics	P3	BB (66)
Gemtuzumab Ozogamicin Myelodysplastic Syndrome	National Cancer Institute (NCI)	P3	BB (66)
Gilteritinib Acute Myeloid Leukemia	European Organisation for Research and Treatment of Cancer - EORTC	P3	BB (66)
Gilteritinib Acute Myeloid Leukemia, FLT3 Internal Tandem Duplication	The First Affiliated Hospital of Soochow University	P3	BB (66)
Girentuximab Nonpapillary Renal Cell Carcinoma	Massachusetts General Hospital	P3	BB (66)
Girentuximab Renal Cell Carcinoma	Telix Pharmaceuticals (Innovations) Pty Limited	P3	BB (66)
Goserelin Estrogen-Receptor Positive Breast Cancer	Memorial Sloan Kettering Cancer Center	P3	BB (66)
Goserelin Prostate Carcinoma	Mayo Clinic	P3	BB (66)
Gozetotide Prostate Cancer	University of Texas Southwestern Medical Center	P3	BB (66)
hdm1002 Obesity Disorder	Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.	P3	BB (66)
Hetrombopag Thrombocytopenia	Sun Yat-sen University	P3	BB (66)
Histrelin Prostate Adenocarcinoma	NRG Oncology	P3	BB (66)
HR20013 Chemotherapy-Induced Toxicity	Fujian Shengdi Pharmaceutical Co., Ltd.	P3	BB (66)
Human Culture Expanded Genetically Modified Autologous T Cells For Cell-Based Gene Therapy. Cells Are Derived From Isolated Blood Of The Patient And Are Transduced With Non-Replicative Self-Inactivating (Sin) Human Immunodeficiency Virus Type 1 (Hiv-1) Based Lentiviral Vector (Lvv) Pseudotyped With The Vesicular Stomatitis Virus Glycoprotein G (Vsv-G) Envelope Protein, And Encoding The C11D5.3 Anti-Tnf Receptor Superfamily Member 17 (Tnfrsf17, Bcma) Single Chain Variable Fragment (Scfv) Cd8/4-1Bb/Cd3Zeta Chimeric Antigen Receptor (Car) Under The Transcriptional Control Of The Myeloproliferative Sarcoma Virus Enhancer, Negative Control Region Deleted, Dl587Rev Primer-Binding Site Substituted (Mnd) Promote Plasma Cell Myeloma	Memorial Sloan Kettering Cancer Center	P3	BB (66)
Humax-Cd20 Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma	PETHEMA Foundation	P3	BB (66)
Hydrocortisone B-Cell Acute Lymphoblastic Leukemia	National Cancer Institute (NCI)	P3	BB (66)
Hydrocortisone Myelodysplastic Syndrome	Andrew E. Place, MD	P3	BB (66)

Showing 2226 to 2250 of 42,301 assets

PreviousPage 90 of 1693Next